Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00208689 · ClinicalTrials.gov registry record

Critical Congenital Heart Defect (CHD) Outcomes in Children

A clinical trial, sponsored by Emory University.

Terminated
Registry status
150
Enrollment target

NCT00208689: Clinical Trial study, sponsored by Emory University.

NCT00208689 is a clinical trial that was terminated before completion, run by Emory University. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00208689 was terminated before completion, sponsored by Emory University.

TERMINATED
Registry status
150 participants
Enrollment target

Study Summary

Congenital heart disease in infants and children often challenges healthcare providers both in regards to diagnosis and in the management of these conditions. The field becomes more complicated as one examines the myriad of defects that present and the complex care that is required. Over the last 20-25 years, the remarkable advances in the medical and surgical management of the most complex lesions have decreased neonatal mortality, such that many more survive the neonatal period. Therefore, new challenges regarding the continued care of this patient cohort of high-risk infants and children exist. In order to continue the improvement of treatment(s) offered to these patients, continuous review and analysis of the current standard of care is needed. In this study, the investigators will collect information related to the current surgical and medical therapies offered to patients enrolled in the High Risk Congenital Heart Program at Children's Healthcare of Atlanta. All of the procedure and visit information will be a part of the child's standard of care. This information will be placed in a database. The investigators hope to learn more about the short-term and long-term effects of current therapies and procedures.

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2004-01
Emory University

1,208 total trials

Why NCT00208689 stopped before completion

NCT00208689 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00208689 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00208689 about?

NCT00208689 is a clinical study titled "Critical Congenital Heart Defect (CHD) Outcomes in Children". Congenital heart disease in infants and children often challenges healthcare providers both in regards to diagnosis and in the management of these conditions. The field becomes more complicated as one examines the myriad of defects that present and the complex care that is required. Over the last 20...

What is the current status of trial NCT00208689?

This trial is currently terminated. The enrollment target is 150 participants. The study started on 2004-01.

Who is sponsoring clinical trial NCT00208689?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00208689, the US trial registry maintained by the National Library of Medicine. NCT00208689 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.